The importance of an extended lymphadenectomy in the management of high-grade invasive bladder cancer

Expert Review of Anticancer Therapy

Volumn 4, Issue 6, 2004, Pages 1007-1016

  Quek, Marcus L ^a   Sanderson, Kristin M ^a   Daneshmand, Siamak ^b   Stein, John ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Bladder neoplasm; Cystectomy; Lymph mode dissection; Lymphadenectomy; Transitional cell carcinoma

Indexed keywords

AUTOPSY; BLADDER CANCER; BLADDER TUMOR; CANCER GRADING; CANCER INVASION; CYSTECTOMY; DENSITY; HISTORY OF MEDICINE; HUMAN; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHATIC DRAINAGE; MORBIDITY; PLASTIC SURGERY; PROGNOSIS; REVIEW; SURGICAL APPROACH; SURGICAL MORTALITY; SURGICAL TECHNIQUE; TRANSITIONAL CELL CARCINOMA; URINARY TRACT SURGERY;

EID: 10644268598     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737140.4.6.1007     Document Type: Review

References (51)

1. Jemal A. Thomas A, Murray T, Thun M. Cancer statistics 2002. CA Cancer J. Clin. 52, 23-47 (2002).
2. Prout G, Marshall VF. The prognosis with untreated bladder tumors. Cancer 9, 551-558 (1956).
3. Stein JP. Indications for early cystectomy. Urology 62, 591-595 (2003).
4. Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J. Clin. Oncol. 19, 666-675 (2001).
5. Leissner J, Ghoneim MA, Abol-Enein H et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J. Urol. 171, 139-144 (2004).
6. Poulsen AL, Horn T, Steven K. Radical cystectomy: extending limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J. Urol. 160, 2015-2020 (1998).
7. Vieweg J, Gschwend JE, Herr HW, Fair WR. The impact of primary stage on survival in patients with lymph node positive bladder cancer. J. Urol. 161, 72-76 (1999).
8. Leissner J, Hohenfellner R, Thuroff JW, Wolf HK. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder: significance for staging and prognosis. BJU Int. 85, 817-823 (2000).
9. Vizina A, Dugi D, Shariat SF, Evans J, Link R, Lerner SP. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J. Urol. 171, 1830-1834 (2004).
10. Brossner C, Pycha A, Toth A, Mian C, Kuber W. Does extended lymphadenectomy increase the morbidity of radical cystectomy? BJU Int. 93, 64-66 (2004).
11. Lebret T, Herve J-M, Lyonneau L et al. After cystectomy, is it justified to perform a bladder replacement for patients with lymph node positive bladder cancer? Eur. Urol. 42, 344-349 (2002).
12. Barth PJ, Gerharz EW, Ramaswamy A et al. The influence of lymph node counts on the detection of pelvic lymph node metastasis in prostate cancer. Pathol. Res. Pract. 195, 633-636 (1999).
13. Daneshmand S, Stein JP, Lieskovsky G et al. Prognosis of patients with stage D1 prostate cancer following radical prostatectomy. J. Urol. 169(4), 397 (2003) (Abstract 1485).
14. Terrone C, Guercio S, DeLuca S et al. The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int. 91, 37-40 (2003).
15. Herrlinger A, Schrott KM, Schott G, Sigel A. What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma? J. Urol. 146, 1224-1227 (1991).
16. Pantuck AJ, Zisman A, Dorey F et al. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J. Urol. 169, 2076-2083 (2003).
17. Halstead WS. The treatment of wounds. Johns Hopkins Hosp. Rep. 2, 279 (1891).
18. Colston JA, Leadbetter WF. Infiltrating carcinoma of the bladder. J. Urol. 36, 669-689 (1936).
19. Jewett HJ, Strong GH. Infiltrating carcinoma of the bladder: relation of depth of penetration of the bladder wall to incidence of local extension and metastases. J. Urol. 55, 366-372 (1946).
20. Kerr WS, Colby FH. Pelvic lymph node dissection and total cystectomy in the treatment of carcinoma of the bladder. J. Urol. 63, 842-851 (1950).
21. Leadbetter WF, Cooper JF. Regional gland dissection for carcinoma of the bladder: a technique of one-stage cystectomy, gland dissection, and bilateral uretero-enterostomy. J. Urol. 63, 242-260 (1950).
22. Whitmore WF, Marshall VF, Radical total cystectomy for cancer of the bladder: 230 consecutive cases five years later. J. Urol. 87, 853-868 (1962).
23. Dretler SP, Ragsdale BD, Leadbetter WF. The value of pelvic lymphadenectomy in the surgical treatment of bladder cancer. J. Urol. 109, 414-416 (1973).
24. Wallace DM. Total cystectomy: an editorial overview. Cancer 32, 1078-1083 (1973).
25. Skinner DG. Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J. Urol. 128, 34-36 (1982).
26. Herr HW. Surgical factors in bladder cancer: more (nodes) + more (pathology) = less (mortality). BJU Int. 92, 187-188 (2003).
27. Konety BR, Joslyn SA, O'Donnell MA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results program data base. J. Urol. 169, 945-950 (2003).
28. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J. Urol. 167, 1295-1298 (2002).
29. Smith JA, Whitmore WF Jr. Regional lymph node metastasis from bladder cancer. J. Urol. 126, 591-593 (1981).
30. Donohue RE, Pfister RR, Weigel JW, Stonington OG. Pelvic lymphadenectomy in stage A prostatic cancer. Urology 9, 273-275 (1977).
31. Wilson CS, Dahl DS, Middleton RG. Pelvic lymphadenectomy for staging of apparently localized prostate cancer. J. Urol. 117, 197-198 (1977).
32. Suzuki T, Kurokawa K, Yamanaks H, Jimbo H. Lymphatic drainage of the prostate gland in canines. Prostate 21, 279-286 (1992).
33. Esrig D, Freeman JA, Stein JP et al. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J. Urol. 156, 1071-1076 (1996).
34. Wishnow KI, Johnson DE, Ro JY, Swanson DA, Babian RJ, vonEschenbach AC. Incidence, extent, and location of unsuspected pelvic lymph node metastasis in patients undergoing radical cystectomy for bladder cancer. J. Urol. 137, 408-410 (1987).
35. Ravery V, Chopin DK, Abbou CC. Anatomie chirurgicale du drainage lymphatique de la vessie. Ann. Urol. 27, 9 (1993).
36. Mills RD, Turner WH, Fleischmann R, Markwalder R, Thalmann GN, Studer UE. Pelvic lymph node metastasis from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J. Urol. 166, 19-23 (2001).
37. Cunningham JH. Tumors of the bladder. J. Urol. 25, 559-587 (1931).
38. Stein JP, Cai J, Groshen S, Skinner DG. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: the concept of lymph node density. J. Urol. 170, 35-41 (2003).
39. Bochner BH, Herr HW, Reuter VE. Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J. Urol. 166, 2295-2296 (2001).
40. Grossman HB, Natale RB, Tangen CM et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N. Engl. J. Med. 349, 859-866 (2003).
41. Eastham JA, Kattan MW, Riedel E et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J. Urol. 170, 2292-2295 (2003).
42. Herr HW, Lee C, Chang, S, Lerner S. Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. J. Urol. 171, 1823-1828 (2004).
43. Crawford ED, Skinner DG. Salvage cystectomy after radiation failure. J. Urol. 123, 32-34 (1980).
44. Quek ML, Stein JP, Clark PE et al. Microscopic and gross extravesical extension in pathologic staging for bladder cancer. J. Urol. 171, 640-645 (2004).
45. Lerner SP, Skinner DG, Lieskovsky G et al. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J. Urol. 149, 758-764 (1993).
46. Vieweg J, Gschwend JE, Herr HW, Fair WR. Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J. Urol. 161, 449-454 (1999).
47. Herr HW. Superiority of ratio based lymph node staging for bladder cancer. J. Urol. 169, 943-945 (2003).
48. Frank I, Cheville JC, Blute ML et al. Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy. Cancer 97, 2425-2431 (2003).
49. Knap MM, Lundbeck F, Overgaard J. The role of pelvic lymph node dissection as a predictive and prognostic factor in bladder cancer. Eur. J. Cancer 39, 604-613 (2003).
50. Vieweg J, Whitmore WF Jr, Herr HW et al. The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. Cancer 73, 3020-3028 (1994).
51. Herr HW. Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology 61, 105-108 (2003).